NCT01914354View on ClinicalTrials.gov

Role of CD28null NKG2Dpos T Cells on Human Alloimmune Reactivity T Cell Population

CompletedOBSERVATIONAL

Enrollment

90

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

June 30, 2014

Conditions

Kidney Transplant

All Listed Sponsors

lead

The Cleveland Clinic

OTHER

NCT01914354 - Role of CD28null NKG2Dpos T Cells on Human Alloimmune Reactivity T Cell Population | Biotech Hunter | Biotech Hunter